This Article
Right arrow Full Text (PDF)
Right arrow Letters to the Editor: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Letters to the Editor are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrowReprints and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fortin, P. T.
Right arrow Articles by Johnson, T. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fortin, P. T.
Right arrow Articles by Johnson, T. M.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Technorati  
What's this?

The Journal of Bone and Joint Surgery, Vol 77, Issue 9 1396-1403, Copyright © 1995 by Journal of Bone and Joint Surgery, Inc


JOURNAL CONTENTS

Malignant melanoma of the foot and ankle

PT Fortin, AA Freiberg, R Rees, VK Sondak and TM Johnson
University of Michigan Medical Center, Ann Arbor, USA.

The records of sixty patients who had a malignant melanoma of the foot or ankle were reviewed retrospectively to determine the clinical features, prognostic factors, and distinguishing characteristics. Fifty-seven patients were white and three were black. There were forty-two women and eighteen men (a female-to-male ratio of 2.3 to 1). The mean age at the time of presentation was fifty-seven years (range, twenty-two to eighty-three years). The most common site of involvement was the plantar aspect of the foot. The mean duration of follow-up was forty-five months (range, three to 144 months). Kaplan-Meier life-table analysis revealed an over-all five-year survival rate of 63 per cent and an over-all ten-year survival rate of 51 per cent. The mean duration of survival for the patients who had a plantar or subungual lesion was significantly shorter than that for the patients who had a lesion at another site on the dorsal aspect of the foot or on the ankle (forty-seven compared with seventy-two months) (p = 0.02). The mean depth of the lesion, according to the criteria of Breslow, was 3.03 millimeters, and the mean level, according to the classification of Clark et al., was IV. According to the classification of the American Joint Commission on Cancer, forty-three patients had stage-I or II (local) disease, thirteen had stage-III disease (nodal or in-transit disease, defined as cutaneous or subcutaneous metastases more than two centimeters from the primary tumor but not beyond the regional lymph nodes), and four had stage-IV disease (distant visceral metastases) at the time of presentation. Lesions at plantar and subungual sites were also associated with a higher prevalence of clinical misdiagnosis compared with lesions on the dorsal aspect of the foot or on the ankle (p = 0.02). The misdiagnoses included a benign nevus (one patient), a paronychia (one patient), a pyogenic granuloma (two patients), a plantar wart (three patients), a ganglion cyst (one patient), a blister (two patients), and a traumatic lesion (five patients).(ABSTRACT TRUNCATED AT 250 WORDS)
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Foot & Ankle SpecialistHome page
H. DeGroot III
Approach to the Management of Soft Tissue Tumors of the Foot and Ankle
Foot & Ankle Specialist, June 1, 2008; 1(3): 168 - 176.
[Abstract] [PDF]


Home page
JBJSHome page
C. D. Toma, M. Dominkus, M. Pfeiffer, P. Giovanoli, O. Assadian, and R. Kotz
Metatarsal Reconstruction with Use of Free Vascularized Osteomyocutaneous Fibular Grafts Following Resection of Malignant Tumors of the Midfoot. A Series of Six Cases
J. Bone Joint Surg. Am., July 1, 2007; 89(7): 1553 - 1564.
[Abstract] [Full Text] [PDF]


Home page
J Am Acad Orthop SurgHome page
G. D. Bos, R. J. Esther, and T. S. Woll
Foot Tumors: Diagnosis and Treatment
J. Am. Acad. Ortho. Surg., July 1, 2002; 10(4): 259 - 270.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Podiatr. Med. Assoc.Home page
H. Lemont and J. Brady
Amelanotic Melanoma Masquerading as an Ingrown Toenail
J Am Podiatr Med Assoc, May 1, 2002; 92(5): 306 - 307.
[Full Text] [PDF]